]. S. Bibliographie1, J. J. Goldie, K. Kim, J. D. Kobus, J. Goldhaber-fiebert et al., Cost-effectiveness of HPV 16, 18 vaccination in Brazil, Vaccine, vol.22, issue.33, pp.256257-6270, 2007.

D. Bernoulli, Essai d'une nouvelle analyse de la mortalité causée par la petite vérole, & des avantages de l'inoculation pour la prévenir, Histoire et Mémoires de l'Académie Royale des Sciences de Paris. Edité dans Die Werke von Daniel Bernoulli, pp.235-267, 1766.

W. O. Kermack and A. G. Mckendrick, A Contribution to the Mathematical Theory of Epidemics, Proceedings of the Royal Society, pp.700-721, 1927.

E. Schwarz, U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck et al., Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature, vol.2, issue.6006, pp.314111-114, 1985.
DOI : 10.1038/314111a0

F. X. Bosch, A. Lorincz, N. Muñoz, C. J. Meijer, and K. V. Shah, The causal relation between human papillomavirus and cervical cancer, Journal of Clinical Pathology, vol.55, issue.4, pp.244-265, 1926.
DOI : 10.1136/jcp.55.4.244

M. Veluire and D. Brasnu, [Evolution of sexual behaviour in France and emergence of new head and neck cancers], Bull Cancer, vol.26, issue.10, pp.981185-1192, 2011.

C. Bergeron, N. Largeron, R. Mcallister, P. Mathevet, and V. Remy, Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France, International Journal of Technology Assessment in Health Care, vol.151, issue.01, pp.10-19, 2008.
DOI : 10.1016/j.vaccine.2007.03.049

J. Monsonego, [Traité des infections et pathologies génitales à papillomavirus, pp.31-52, 2007.
DOI : 10.1007/978-2-287-72066-6

K. Syrjnen, M. Hakama, S. Saarikoski, M. Vyrynen, M. Yliskoski et al., Prevalence, Incidence, and Estimated Life-time Risk of Cervical Human Papillomavirus Infections in a Nonselected Finnish Female Population, Sexually Transmitted Diseases, vol.17, issue.1, pp.15-24, 1990.
DOI : 10.1097/00007435-199017010-00004

A. M. Sanchez, J. Nowakowski, N. Bornstein, F. X. Muñoz, . Bosch et al., Time Trends Study Group . Human papillomavirus genotype attribution in invasive cervical cancer : a retrospective cross-sectional worldwide study, Lancet Oncol, vol.11, issue.11, pp.1048-1056, 2010.

C. Pannier-stockman, C. Segard, S. Bennamar, J. Gondry, J. C. Boulanger et al., Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities, Journal of Clinical Virology, vol.42, issue.4, pp.353-360, 2008.
DOI : 10.1016/j.jcv.2008.03.022

J. Peto, C. Gilham, J. Deacon, C. Taylor, C. Evans et al., Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort, British Journal of Cancer, vol.88, issue.5, pp.91942-953, 2004.
DOI : 10.1038/sj.bjc.6602049

A. M. Johnson, C. H. Mercer, S. Beddows, N. De-silva, S. Desai et al., Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain, Sexually Transmitted Infections, vol.88, issue.3, pp.212-217, 2012.
DOI : 10.1136/sextrans-2011-050306

N. Muñoz, Human papillomavirus and cancer: the epidemiological evidence, Journal of Clinical Virology, vol.19, issue.1-2, pp.1-5, 2000.
DOI : 10.1016/S1386-6532(00)00125-6

B. Shin, H. Storm, H. Ferlay, J. Heanue, M. Curado et al., Cancer incidence in five continents. volume ix, IARC Sci Publ, issue.160, pp.1-837, 2007.

M. Foucard, L. Colonna, G. Daubisse, G. Hédelin, N. L. Launoy et al., Cancer incidence and mortality in france over the period, pp.159-175, 1980.
URL : https://hal.archives-ouvertes.fr/hal-00428273

N. Duport, Données épidémiologiques sur le cancer du col de l'utérus. Etats des connaissances-Actualisation, InVS, p.33, 2008.

H. D. Vuyst, G. M. Clifford, M. C. Nascimento, M. M. Madeleine, and S. Franceschi, Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis, International Journal of Cancer, vol.50, issue.7, pp.1626-1636, 2009.
DOI : 10.1002/ijc.24116

F. U. Ii-study and . Group, Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions, N Engl J Med, vol.356, issue.19, pp.1915-1927, 1933.

F. U. Ii-study and . Group, Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection

A. Hildesheim, R. Herrero, S. Wacholder, A. C. Rodriguez, D. Solomon et al., Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection, JAMA, vol.298, issue.7, pp.298743-753, 2007.
DOI : 10.1001/jama.298.7.743

U. R. Investigators, Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases, N Engl J Med, vol.356, issue.19, pp.1928-1943, 1933.

L. L. Myers, F. J. Villa, C. Taddeo, A. Roberts, J. Tadesse et al., HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine, Vaccine, issue.52, pp.266844-6851, 2008.

S. Esser, R. M. Vuocolo, E. Haupt, A. Barr, and . Saah, Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombi- BIBLIOGRAPHIE nant vaccine in women aged 24-45 years : a randomised, double-blind trial, Lancet, issue.9679, pp.3731949-1957, 2009.

D. G. Tang, J. Ferris, M. Paavonen, M. Lehtinen, F. X. Steben et al., Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts : randomised controlled trial, BMJ, vol.341, pp.3493-3526, 2010.

X. Castellsagué, N. Muñoz, P. Pitisuttithum, D. Ferris, J. Monsonego et al., End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24???45 years of age, British Journal of Cancer, vol.356, issue.1, pp.28-37, 2011.
DOI : 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.3.CO;2-6

A. R. Kreimer, P. González, H. A. Katki, C. Porras, M. Schiffman et al., Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial, The Lancet Oncology, vol.12, issue.9, pp.862-870, 2011.
DOI : 10.1016/S1470-2045(11)70213-3

J. M. Palefsky, A. R. Giuliano, S. Goldstone, E. D. Moreira, C. Jr et al., HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia, New England Journal of Medicine, vol.365, issue.17, pp.3651576-1585, 2011.
DOI : 10.1056/NEJMoa1010971

D. Haupt, E. I. Guris, and . Garner, Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults, Hum Vaccin, vol.7, issue.7, pp.768-775, 2011.

D. Haupt, E. I. Guris, and . Garner, Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old, Clin Vaccine Immunol, vol.19, issue.2, pp.261-267, 2012.

H. L. Giacoletti, M. Sings, T. M. James, E. Hesley, and . Barr, The impact of quadrivalent human papillomavirus (hpv ; types 6, 11, 16, and 18) l1 virus-like particle BIBLIOGRAPHIE vaccine on infection and disease due to oncogenic nonvaccine hpv types in generally hpv-naive women aged 16-26 years, J Infect Dis, issue.7, pp.199926-935, 2009.

J. Paavonen, P. Naud, J. Salmerón, C. M. Wheeler, S. Chow et al., Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women, The Lancet, vol.374, issue.9686, pp.374301-314, 2009.
DOI : 10.1016/S0140-6736(09)61248-4

D. M. Bosch, W. Harper, K. Huh, T. Hardt, D. Zahaf et al., Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types : 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial, Lancet Oncol, vol.13, issue.1, pp.100-110, 1934.

H. De-arazoza and R. Lounes, A non-linear model for a sexually transmitted disease with contact tracing, Mathematical Medicine and Biology, vol.19, issue.3, pp.221-234, 2002.
DOI : 10.1093/imammb/19.3.221
URL : https://hal.archives-ouvertes.fr/hal-00171290

J. Guedj, R. Thiébaut, and D. Commenges, Practical Identifiability of HIV Dynamics Models, Bulletin of Mathematical Biology, vol.48, issue.8, pp.2493-2513, 2007.
DOI : 10.1007/s11538-007-9228-7
URL : https://hal.archives-ouvertes.fr/inserm-00204273

]. A. Flahault, E. Vergu, and P. Y. Boëlle, Potential for a global dynamic of Influenza A (H1N1), BMC Infectious Diseases, vol.3, issue.1, pp.129-163, 2009.
DOI : 10.1371/journal.pone.0001478
URL : https://hal.archives-ouvertes.fr/inserm-00663615

D. Lévy-bruhl, [contribution of mathematical modeling to vaccination decision making . examples from varicella, rotavirus and papillomavirus vaccinations], Bull Acad Natl Med, vol.194, issue.8, pp.1545-56, 2010.

G. P. Garnett, S. Cousens, T. B. Hallett, R. Steketee, and N. Walker, Mathematical models in the evaluation of health programmes, The Lancet, vol.378, issue.9790, pp.515-525, 2011.
DOI : 10.1016/S0140-6736(10)61505-X

E. J. Dasbach, E. H. Elbasha, and R. P. Insinga, Mathematical Models for Predicting the Epidemiologic and Economic Impact of Vaccination against Human Papillomavirus Infection and Disease, Epidemiologic Reviews, vol.28, issue.1, pp.88-100, 2006.
DOI : 10.1093/epirev/mxj006

J. P. Hughes, G. P. Garnett, and L. Koutsky, The Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus Vaccine, Epidemiology, vol.13, issue.6, pp.631-639, 2002.
DOI : 10.1097/00001648-200211000-00006

A. V. Taira, C. P. Neukermans, and G. D. Sanders, Evaluating Human Papillomavirus Vaccination Programs, Emerging Infectious Diseases, vol.10, issue.11, pp.1915-1923, 2004.
DOI : 10.3201/eid1011.040222
URL : http://doi.org/10.3201/eid1011.040222

J. J. Kim, B. Andres-beck, and S. J. Goldie, The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting, British Journal of Cancer, vol.10, issue.3, pp.1322-1328, 2007.
DOI : 10.1046/j.1524-4733.2003.00234.x

J. A. Bogaards, V. M. Coupé, M. Xiridou, C. J. Lm, J. Meijer et al., Long-term Impact of Human Papillomavirus Vaccination on Infection Rates, Cervical Abnormalities, and Cancer Incidence, Epidemiology, vol.22, issue.4, pp.505-515, 2011.
DOI : 10.1097/EDE.0b013e31821d107b

V. Brown and K. A. White, The HPV Vaccination Strategy: Could Male Vaccination Have a Significant Impact?, Computational and Mathematical Methods in Medicine, vol.11, issue.3, pp.223-237, 2010.
DOI : 10.1080/17486700903486613

R. V. Barnabas, P. Laukkanen, P. Koskela, O. Kontula, M. Lehtinen et al., Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses, PLoS Medicine, vol.42, issue.5, pp.138-118, 1993.
DOI : 10.1371/journal.pmed.0030138.st004

I. Baussano, G. Ronco, N. Segnan, K. French, P. Vineis et al., HPV-16 infection and cervical cancer: Modeling the influence of duration of infection and precancerous lesions, Epidemics, vol.2, issue.1, pp.21-28, 2010.
DOI : 10.1016/j.epidem.2010.02.002

E. H. Elbasha, Impact of prophylactic vaccination against human papillomavirus infection, Contemporary Math, vol.410, issue.40, p.63, 2006.
DOI : 10.1090/conm/410/07723

E. H. Elbasha, E. J. Dasbach, and R. P. Insinga, Model for Assessing Human Papillomavirus Vaccination Strategies, Emerging Infectious Diseases, vol.13, issue.1, pp.28-41, 2007.
DOI : 10.3201/eid1301.060438

E. H. Elbasha, E. J. Dasbach, and R. P. Insinga, A Multi-Type HPV Transmission Model, Bulletin of Mathematical Biology, vol.191, issue.2, pp.2126-2176, 2008.
DOI : 10.1007/s11538-008-9338-x

E. H. Elbasha and E. J. Dasbach, Impact of vaccinating boys and men against HPV in the United States, Vaccine, vol.28, issue.42, pp.6858-6867, 1993.
DOI : 10.1016/j.vaccine.2010.08.030

E. J. Dasbach, N. Largeron, and E. H. Elbasha, Assessment of the cost???effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission model, Expert Review of Pharmacoeconomics & Outcomes Research, vol.8, issue.5, pp.491-500, 2008.
DOI : 10.1586/14737167.8.5.491

N. Van-de-velde, M. Brisson, and M. C. Boily, Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis, Vaccine, vol.28, issue.33, pp.5473-5484, 2010.
DOI : 10.1016/j.vaccine.2010.05.056

A. Capurro, Z. Feng, and C. Castillo-chavez, A model for tuberculosis with exogenous reinfection, Theor Popul Biol, vol.57, pp.235-282, 2000.

M. Nuño, Z. Feng, M. Martcheva, and C. Castillo-chavez, Dynamics of two-strain influenza with isolation and partial cross-immunity. evolution, pp.4-40

E. H. Elbasha, Global Stability of Equilibria in a Two-Sex HPV Vaccination Model, Bulletin of Mathematical Biology, vol.95, issue.8, pp.894-909, 2008.
DOI : 10.1007/s11538-007-9283-0

E. H. Elbasha and A. P. Galvani, Vaccination against multiple HPV types, Mathematical Biosciences, vol.197, issue.1, pp.88-117, 2005.
DOI : 10.1016/j.mbs.2005.05.004

K. Dietz, The estimation of the basic reproduction number for infectious diseases, Statistical Methods in Medical Research, vol.154, issue.1
DOI : 10.1177/096228029300200103

O. Diekmann, K. Dietz, and J. A. Heesterbeek, The basic reproduction ratio for sexually transmitted diseases: I. theoretical considerations, Mathematical Biosciences, vol.107, issue.2, pp.325-339, 1991.
DOI : 10.1016/0025-5564(91)90012-8

R. Ross, The prevention of malaira, 2nd Edition, with an addendum on the theory of happenings, p.47, 1911.

G. Macdonald, The epidemiology and control of malaria, p.47, 1957.

N. T. Bailey, The mathematical theory of infectious disease and its applications

S. Hirsch and M. W. Smale, Differential equations, dynamical systems, and linear algebra, p.47, 1974.

S. Devaney, R. L. Hirsch, and M. W. Smale, Differential Equations, dynamical systems and introduction to chaos, p.48, 2003.

C. Brauer and F. Castillo-chavez, Mathematical models in population Biology and epidemiology, Texts in Applied Mathematics, vol.40, p.48, 2000.

P. Van-den-driessche and J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Mathematical Biosciences, vol.180, issue.1-2, pp.29-48, 2002.
DOI : 10.1016/S0025-5564(02)00108-6

O. Diekmann, J. A. Heesterbeek, M. G. Roberts-]-o, J. A. Diekmann, J. A. Heesterbeek et al., The construction of next-generation matrices for compartmental epidemic models, Journal of The Royal Society Interface, vol.180, issue.5, pp.873-885365, 1990.
DOI : 10.1016/S0025-5564(02)00108-6

. Gantmacher, The Theory of Matrices, p.58, 1959.

J. K. Hale, Ordinary Differential Equations, p.59, 1969.

J. C. Butcher, Numerical methods for Ordinary Differential Equations, p.69, 2003.

H. W. Hethcote, An age-structured model for pertussis transmission, Mathematical Biosciences, vol.145, issue.2, pp.89-136, 1997.
DOI : 10.1016/S0025-5564(97)00014-X

M. Grosclaude, P. Bossard, N. Launoy, G. Remontet, L. Benhamou et al., Estimation nationale de l'incidence et de la mortalité par cancer en france entre, p.72, 1980.

N. Bajos, M. Bozon, and N. Beltzer, Enquête sur la sexualité en France. Pratiques, genre et santé, p.79, 2006.

G. P. Garnett and R. M. Anderson, Contact Tracing and the Estimation of Sexual Mixing Patterns, Sexually Transmitted Diseases, vol.20, issue.4, pp.181-191, 1993.
DOI : 10.1097/00007435-199307000-00001

V. Capasso, Mathematical Structures of Epidemic Systems, p.88, 1993.
DOI : 10.1007/978-3-540-70514-7

L. Abramowitz, A. C. Jacquard, F. Jaroud, J. Haesebaert, L. Siproudhis et al., Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study, International Journal of Cancer, vol.20, issue.Suppl 10, pp.433-439, 2011.
DOI : 10.1002/ijc.25671
URL : https://hal.archives-ouvertes.fr/hal-00563122

H. Study, Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France : EDITH study, Int J Cancer, vol.122, issue.2, pp.428-432, 1992.

J. L. Prétet, A. C. Jacquard, X. Carcopino, S. Monnier-benoit, G. Averous et al., Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study, International Journal of Cancer, vol.367, issue.Suppl 3, pp.424-427, 1992.
DOI : 10.1002/ijc.23093

J. L. Prétet, A. C. Jacquard, M. Saunier, C. Clavel, R. Dachez et al., Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer, Gynecologic Oncology, vol.110, issue.2, pp.179-184, 2008.
DOI : 10.1016/j.ygyno.2008.04.012

J. S. Smith, P. A. Gilbert, A. Melendy, R. K. Rana, and J. M. Pimenta, Age-Specific Prevalence of Human Papillomavirus Infection in Males: A Global Review, Journal of Adolescent Health, vol.48, issue.6, pp.540-552, 2011.
DOI : 10.1016/j.jadohealth.2011.03.010

C. M. Nielson, R. B. Harris, R. Flores, M. Abrahamsen, M. R. Papenfuss et al., Multiple-Type Human Papillomavirus Infection in Male Anogenital Sites: Prevalence and Associated Factors, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.4, pp.1077-1083, 2009.
DOI : 10.1158/1055-9965.EPI-08-0447

H. E. Ralston, Z. Li, . Mcglennen, L. Hellerstedt, and . Downs-jr, Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening, American Journal of Obstetrics and Gynecology, vol.200, issue.3, pp.245-108, 2009.
DOI : 10.1016/j.ajog.2008.10.050

G. S. Ogilvie, D. L. Taylor, M. Achen, D. Cook, and M. Krajden, Self-collection of genital human papillomavirus specimens in heterosexual men, Sexually Transmitted Infections, vol.85, issue.3, pp.221-225, 2009.
DOI : 10.1136/sti.2008.033068

I. Baussano, G. Ronco, N. Segnan, K. French, P. Vineis et al., HPV-16 infection and cervical cancer: Modeling the influence of duration of infection and precancerous lesions, Epidemics, vol.2, issue.1, pp.21-28, 2010.
DOI : 10.1016/j.epidem.2010.02.002

I. Baussano, G. Garnett, N. Segnan, G. Ronco, and P. Vineis, Modelling patterns of clearance of HPV-16 infection and vaccination efficacy, Vaccine, vol.29, issue.6, pp.1270-1277, 2011.
DOI : 10.1016/j.vaccine.2010.11.082

J. P. Fagot, A. Boutrelle, P. Ricordeau, A. Weill, and H. Allemand, HPV vaccination in France: Uptake, costs and issues for the National Health Insurance, Vaccine, vol.29, issue.19, pp.3610-3616, 2011.
DOI : 10.1016/j.vaccine.2011.02.064

J. M. Brotherton, S. L. Deeks, S. Campbell-lloyd, A. Misrachi, I. Passaris et al., Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia, Commun Dis Intell, vol.32, issue.4, pp.457-461, 2008.

W. J. Conover, Practical Nonparametric statistics, p.100, 1980.

C. M. Nielson, Type-specific prevalence and persistence of Human Papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening, Am J Obstet Gynecol, vol.200, issue.3, pp.245-108, 2009.

T. R. Read, J. S. Hocking, M. Y. Chen, B. Donovan, C. S. Bradshaw et al., The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme, Sexually Transmitted Infections, vol.87, issue.7, pp.544-547, 0109.
DOI : 10.1136/sextrans-2011-050234

G. Y. Ho, Y. Y. Studentsov, R. Bierman, and R. D. Burk, Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women, Cancer Epidemiology Biomarkers & Prevention, vol.13, issue.1, pp.110-116, 0115.
DOI : 10.1158/1055-9965.EPI-03-0191

G. J. Van-doornum, M. Prins, L. H. Juffermans, C. Hooykaas, J. A. Van-den-hoek et al., Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study., Sexually Transmitted Infections, vol.70, issue.4, pp.240-246, 1994.
DOI : 10.1136/sti.70.4.240

A. Wikström, C. Popescu, and O. Forslund, Asymptomatic Penile HPV Infection: A Prospective Study, International Journal of STD & AIDS, vol.186, issue.2, pp.80-84, 2000.
DOI : 10.1126/science.2999980

S. K. Kjaer, C. Munk, J. F. Winther, H. O. Jorgensen, C. J. Meijer et al., Acquisition and Persistence of Human Papillomavirus Infection in Younger Men: A Prospective Follow-up Study among Danish Soldiers, Cancer Epidemiology Biomarkers & Prevention, vol.14, issue.6, pp.141528-1533, 2005.
DOI : 10.1158/1055-9965.EPI-04-0754

E. Avila and . Lazcano-ponce, Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men, Cancer Epidemiol Biomarkers Prev, vol.14, issue.7, pp.1710-1716, 2005.

J. M. Partridge, J. P. Hughes, Q. Feng, R. L. Winer, B. A. Weaver et al., Genital Human Papillomavirus Infection in Men: Incidence and Risk Factors in a Cohort of University Students, The Journal of Infectious Diseases, vol.196, issue.8, pp.1961128-1136, 2007.
DOI : 10.1086/521192

W. Hollingworth, J. J. Tsevat, D. Wong, and . Eddy, Model Transparency and Validation : A report of the ISPOR-SMDM Modeling Good Research Practicies Task Force-7

L. Annemans, V. Rémy, J. Oyee, and N. Largeron, Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium, PharmacoEconomics, vol.28, issue.3, pp.231-245, 2009.
DOI : 10.2165/00019053-200927030-00006

M. Brisson, N. Van-de-velde, P. De-wals, and M. C. Boily, The potential costeffectiveness of prophylactic human papillomavirus vaccines in Canada, Vaccine, issue.29, pp.255399-5408, 2007.

. Kim, Cost-effectiveness of human papillomavirus vaccination and screening in Spain

Y. H. Choi, M. Jit, N. Gay, A. Cox, G. P. Garnett et al., Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom, Vaccine, vol.28, issue.24, pp.284091-4102, 0118.
DOI : 10.1016/j.vaccine.2009.09.125

M. Jit, R. Chapman, O. Hughes, and Y. H. Choi, Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model, BMJ, vol.343, issue.sep27 1, pp.5775-119, 2011.
DOI : 10.1136/bmj.d5775

L. Abramowitz, V. Rémy, and A. Vainchtock, Economic burden of anal cancer management in France, Revue d'??pid??miologie et de Sant?? Publique, vol.58, issue.5, pp.331-338, 2010.
DOI : 10.1016/j.respe.2010.06.165